Total comprehensive income for the period, net of tax
-44 078
-71 268
-82 980
-123 984
-170 738
Statements of financial position
(in NOK thousand)
Note
30 June 2026
30 June 2025
31 Dec 2025
Assets
Intangible assets
4
83 975
82 331
84 508
Assets under construction
4
2 411 303
1 035 383
1 781 081
Buildings and property
4
1 495 963
1 510 570
1 516 707
Fixtures and fittings
4
281 675
286 808
289 282
Right-of-use assets
4
41 870
48 255
45 513
Investment in associated companies
4 159
8 804
6 073
Other long-term receivables
13 169
0
13 169
Total non-current assets
4 332 114
2 972 149
3 736 332
Inventory
3
11 817
9 654
11 351
Biological assets
3
206 852
195 512
232 335
Trade receivables
39 864
44 889
10 314
Other current receivables
45 278
68 875
51 585
Financial derivatives
5
17 183
8 527
10 254
Cash and cash equivalents
280 561
128 760
163 438
Total current assets
601 556
456 216
479 276
Total assets
4 933 669
3 428 366
4 215 608
Equity and liabilities
Share capital
8
27 700
23 130
23 130
Share premium
8
2 803 321
2 415 049
2 414 997
Other reserves
14 284
12 192
13 310
Uncovered losses
-471 744
-350 386
-388 765
Total equity
2 373 561
2 099 985
2 062 673
Long-term interest-bearing debt
9
2 073 031
818 500
1 545 228
Lease liabilities - long term
9
27 041
32 595
30 088
Other long-term liabilities
9
3 643
3 643
3 643
Total non-current liabilities
2 103 715
854 738
1 578 959
Short-term interest-bearing debt
9
209 235
207 253
334 571
Trade payables
198 559
234 382
192 047
Social security and other taxes
3 557
5 681
7 527
Lease liabilities - short term
9
10 910
10 481
10 987
Other short-term liabilities
34 134
15 845
28 842
Total current liabilities
456 394
473 642
573 975
Total liabilities
2 560 109
1 328 380
2 152 934
Total equity and liabilities
4 933 669
3 428 366
4 215 607
Statement of cash flow
(in NOK thousand)
Note
Q2 2026
Q2 2025
YTD 2026
YTD 2025
2025
Profit/loss before tax
-43 436
-71 746
-81 627
-126 447
-171 601
Adjustments for:
Depreciation, amortisation and impairment loss
4
20 121
21 190
40 848
42 512
84 473
Net financials
6 698
15 878
6 724
25 909
28 324
Share based payment expenses
487
355
973
709
1 827
Changes in working capital:
Change in trade receivables
44 458
4 395
-29 551
45 188
67 598
Change in other current receivables
-6 140
-8 196
-4 965
-11 034
-3 808
Change in inventory and biological assets
3
-39 867
-2 923
-7 304
-50 055
-41 438
Change in fair value of biomass
3
5 499
9 022
32 364
28 278
-15 630
Change in trade payables
-7 577
-1 693
265
5 107
-4 937
Change in social security and other taxes
761
595
-3 972
-1 404
442
Change in other current liabilities
-4 679
-763
-2 263
792
-1 511
Cash (outflow) from operations
-23 674
-33 886
-48 507
-40 445
-56 261
Cash flow from investment activities
Payments for fixed assets
4
-243 081
-272 782
-533 400
-513 689
-1 260 474
Proceeds from government grants
0
0
0
0
2 258
Payments for intangible assets
4
7
-530
-315
-1 424
-3 960
Financial income received
2 546
1 501
4 402
2 593
9 746
Net cash (outflow) from investment activities
-240 528
-271 811
-529 313
-512 520
-1 252 431
Cash flow from financing activities
Proceeds from issue of equity, net paid transaction costs
8
392 895
0
392 895
0
0
Proceeds from new borrowings
9
237 569
89 716
563 067
392 765
1 153 412
Repayment of borrowings
-160 300
-46 000
-160 600
-94 600
-1 200
Payments of principal portion of lease liabilities
-2 511
-5 135
-5 113
-7 053
-12 173
Interest paid lease liabilities
-630
-693
-1 293
-1 104
-2 503
Financial expenses paid
-59 552
-21 314
-94 011
-37 746
-92 078
Net cash (outflow) from financing activities
407 470
16 574
694 944
252 262
1 045 458
Net change in cash and cash equivalents
143 267
-289 123
117 124
-300 703
-263 233
Cash and cash equ. at the beginning of the period
137 294
417 884
163 438
429 462
429 462
Cash and cash equ. at the end of the period
280 561
128 761
280 561
128 759
163 438
Statement of Changes in Equity
(in NOK thousand)
Note
Share capital
Share premium
Other reserves
Other equity
Uncovered losses
Total equity
Balance at 1 January 2025
8
23 130
2 415 049
11 483
0
-226 402
2 223 260
Profit/loss for the period
0
0
0
0
-126 447
-126 447
Other comprehensive income
0
0
0
0
2 463
2 463
Total comprehensive income
0
0
0
0
-123 984
-123 984
Share based payment expensed
709
709
Transactions with owners
0
0
709
0
0
709
Balance at 30 June 2025
8
23 130
2 415 049
12 192
0
-350 386
2 099 985
Balance at 1 January 2026
8
23 130
2 414 997
13 310
0
-388 765
2 062 673
Profit/loss for the period
0
0
0
0
-81 627
-81 627
Other comprehensive income
0
0
0
0
-1 353
-1 353
Total comprehensive income
0
0
0
0
-82 980
-82 980
Private placement April 2026
8
4 570
388 324
0
0
0
392 894
Other paid-in capital
0
0
0
0
0
0
Share based payment expensed
0
0
973
0
0
973
Transactions with owners
4 570
388 324
973
0
0
393 867
Balance at 30 June 2026
8
27 700
2 803 321
14 284
0
-471 744
2 373 561
Selected notes to the quarterly financial statements
Note 1 Summary of significant accounting policies
General information
Salmon Evolution ASA and its subsidiaries, Salmon Evolution Norway AS, Salmon Evolution International AS, Salmon Evolution Dale AS, Salmon Evolution Sales AS and Salmon Evolution Technology AS (the “Company”, "SE" or "the Company") is a Norwegian land-based salmon farmer headquartered in Hustadvika kommune in Møre og Romsdal.
Salmon Evolution operates a hybrid flow-through (HFS) system, utilizing fresh seawater from the Norwegian coast. The Company is building a land-based salmon farming facility at Indre Harøy, with a planned annual production of 36,000 tons HOG fully built. Phase 1, with a planned annual production of 7,900 tons HOG, is fully operational, whilst construction of phase 2 planned to add an addition 10,100 tons HOG bringing total production up to 18,000 tons HOG was initiated in August 2024.
These interim financial statements were approved by the Board of Directors on 17 August 2026.
These interim financial statements have not been audited.
Consolidation
These condensed consolidated statements for the period ended 30 June 2026 include Salmon Evolution ASA together with its subsidiaries Salmon Evolution Norway AS, Salmon Evolution International AS, Salmon Evolution Dale AS, Salmon Evolution Sales AS and Salmon Evolution Technology AS.
Basis of preparation
These interim financial statements have been prepared in accordance with International Accounting Standard 34, "Interim financial reporting". These interim financial statements do not provide the same scope of information as the annual financial statement and should therefore be read in conjunction with the annual financial statements for the year ended 31 December 2025, which have been prepared in accordance with IFRS® Accounting Standards as adopted by the EU.
Going concern
The Company has adopted the going concern basis in preparing its consolidated financial statements. When assessing this assumption, management has assessed all available information about the future. After making such assessments, management has a reasonable expectation that the Company has adequate resources to continue its operational existence for the foreseeable future.
Accounting policies
The accounting policies adopted are consistent with those of the previous financial year except that income tax expense is recognized in each interim period using the expected weighted average annual income tax rate for the full financial year. Taxes on income in the interim periods are accrued using the tax rate that would be applicable to expected total annual profit or loss. The Company does not include net deferred tax benefits in its balance that exceeds the tax effect of group contributions in order to equalize tax payable in its subsidiaries.
Revenue
Revenue from contracts with customers as defined in IFRS 15 is recognised when control of the goods is transferred to the customer at an amount that reflects the consideration to which the group expects to be entitled in exchange for those goods.
Revenue for the Company derives from sale of whole and processed salmon in the spot marked. The Company recognised revenue at the point in time when control of the goods is transferred to the customer at an amount that reflects the expected amount that the group is entitled to have for the goods. The sales price is based on available market price where the price will vary with both quality and size.
Normal credit term of the sales transactions is 30 days. If the delivered products have discrepancies compared to the agreed sales contract, cash refunds are given to the customer. Up until now, refunds are not material.
Property, plant & equipment
Property, plant, and equipment is measured at cost, which includes capitalized borrowing costs, less accumulated depreciation and costs include expenditures that are directly attributable to the acquisition and placement of fixed assets in service. Costs of major replacements and renewals that substantially extend the economic life and functionality of fixed asset are capitalized. Costs associated with normal maintenance and repairs are expensed as incurred.
Assets are normally considered property, plant, and equipment if the useful economic life exceeds one year. Straight-line depreciation is applied over the useful life of property, plant, and equipment based on the asset’s historical cost. If a substantial part of an asset has an individual and different useful life, that portion is depreciated separately. The asset’s residual value and useful life are evaluated annually. Gains or losses arising from the disposal or retirement of an asset are determined as the difference between the sales proceeds and the carrying amount of the asset and recognized as part of other income in the accompanying statements of other comprehensive income.
Depreciation is charged to expense when the property, plant or equipment is ready for intended use. For the second phase build out, which expected to be ready for intended use during 2026, assets under construction is not depreciated.
Biological assets
Biological assets are, in accordance with IAS 41, measured at fair value unless the fair value cannot be measured reliably. For salmon in the grow-out facility, a present value model is applied to estimate the fair value. For roe, fry and smolt, historical cost is deemed to provide the best estimate of fair value, and hence applied.
Cost of production is adjusted for unutilized production capacity. The Company has started to take some costs related to the preparation and testing of phase 2.
For further information, please refer to note 3.
Borrowing costs
In accordance with IAS 23, the Company’s loan agreements are subject to the following principles relating to borrowing costs:
General and specific borrowing costs that are attributable to the acquisition, construction or production of a qualifying asset are capitalized during the period of time that is required to complete and prepare the asset for its intended use or sale. Qualifying assets are assets that necessarily take a substantial period of time to get ready for their intended use or sale.
Application of IAS 23 has been taken into consideration where the Group has general borrowings which has partly been financing qualifying assets but not been directly allocated to the construction of a qualifying asset. See note 5 for more information.
Other borrowing costs are expensed in the period in which they are incurred.
Note 2 Segment
The Company has implemented segment reporting which consists of production of farmed salmon in Norway (Farming Norway), other activities (Other), and eliminations. The segment performance is monitored to assess performance and profitability at a strategic level.
Farming Norway consists of Salmon Evolution Norway AS (grow-out facility), Salmon Evolution Dale AS (smolt facility) and Salmon Evolution Sales AS. Additionally a portion of the Group overhead costs is allocated to the segment. Other consist of both revenue and costs not attributable to the farming segment.
Sales revenue from contracts with customers comes from both Europe, UK, Asia, US and other markets.
Q2 2026 (In thousand NOK)
Farming Norway
Other
Eliminations
Group
External revenue
66 615
70
0
66 685
Internal revenue
0
9 166
-9 166
0
Operating revenue
66 615
9 236
-9 166
66 685
Change in inventory
39 153
0
0
39 153
Cost of materials
-55 117
0
0
-55 117
Personnel expenses
-14 117
-12 278
9 166
-17 229
Other operating expenses
-39 555
-5 055
0
-44 610
Operational EBITDA
-3 022
-8 097
0
-11 118
Operational EBIT
-22 699
-9 014
474
-31 239
Fair value adjustment of biomass
-5 499
0
0
-5 499
Net financial
-40 910
34 212
0
-6 698
Profit/loss before tax
-69 108
25 198
474
-43 436
Harvested volum (tonnes, HOG)
945
945
Operational EBITDA/kg (NOK)
-3,2
-11,8
Operational EBIT/kg (NOK)
-24,0
-33,1
Total PPE
4 278 975
32 968
2 843
4 314 786
Q2 2025 (In thousand NOK)
Farming Norway
Other
Eliminations
Group
External revenue
90 244
897
0
91 141
Internal revenue
0
7 064
-7 064
0
Operating revenue
90 244
7 961
-7 064
91 141
Change in inventory
1 557
0
0
1 557
Cost of materials
-42 214
0
-5 891
-48 105
Personnel expenses
-13 785
-12 568
6 566
-19 787
Other operating expenses
-49 048
-7 803
6 389
-50 462
Operational EBITDA
-13 247
-12 410
0
-25 656
Operational EBIT
-33 919
-13 402
475
-46 846
Fair value adjustment of biomass
-9 022
0
0
-9 022
Net financial
-46 505
30 627
-0
-15 878
Profit/loss before tax
-89 447
17 225
475
-71 746
Harvested volum (tonnes, HOG)
1 232
1 232
Operational EBITDA/kg (NOK)
-10,8
-20,8
Operational EBIT/kg (NOK)
-27,5
-38,0
Total PPE
2 929 439
90 681
-56 775
2 963 345
YTD 2026 (In thousand NOK)
Farming Norway
Other
Eliminations
Group
External revenue
218 853
70
0
218 923
Internal revenue
0
18 750
-18 750
0
Operating revenue
218 853
18 820
-18 750
218 923
Change in inventory
6 576
0
0
6 576
Cost of materials
-101 133
0
0
-101 133
Personnel expenses
-28 875
-26 052
18 750
-36 177
Other operating expenses
-80 818
-9 062
0
-89 880
Operational EBITDA
14 603
-16 294
0
-1 691
Operational EBIT
-25 308
-18 179
948
-42 539
Fair value adjustment of biomass
-32 364
0
0
-32 364
Net financial
-69 343
62 620
0
-6 724
Profit/loss before tax
-127 015
44 440
948
-81 627
Harvested volum (tonnes, HOG)
2 710
2 710
Operational EBITDA/kg (NOK)
5,4
-0,6
Operational EBIT/kg (NOK)
-9,3
-15,7
Total PPE
4 278 975
32 968
2 843
4 314 786
YTD 2025 (In thousand NOK)
Farming Norway
Other
Eliminations
Group
External revenue
139 912
897
0
140 809
Internal revenue
0
14 717
-14 717
0
Operating revenue
139 912
15 614
-14 717
140 809
Change in inventory
40 504
0
8 573
49 077
Cost of materials
-80 082
0
-7 776
-87 858
Personnel expenses
-29 281
-25 294
14 717
-39 858
Other operating expenses
-78 640
-12 480
-797
-91 917
Operational EBITDA
-7 587
-22 161
0
-29 748
Operational EBIT
-47 966
-25 243
949
-72 259
Fair value adjustment of biomass
-28 278
0
0
-28 278
Net financial
-85 228
59 319
-0
-25 909
Profit/loss before tax
-161 473
34 077
949
-126 447
Harvested volum (tonnes, HOG)
1 813
1 813
Operational EBITDA/kg (NOK)
-4,2
-16,4
Operational EBIT/kg (NOK)
-26,5
-39,9
Total PPE
2 929 439
90 681
-56 775
2 963 345
FY 2025 (In thousand NOK)
Farming Norway
Other
Eliminations
Group
External revenue
325 250
772
0
326 022
Internal revenue
0
33 500
-33 500
0
Operating revenue
325 250
34 272
-33 500
326 022
Change in inventory
43 711
0
0
43 711
Cost of materials
-205 055
0
1 991
-203 064
Personnel expenses
-49 976
-53 044
22 022
-80 998
Other operating expenses
-153 413
-20 431
9 487
-164 357
Operational EBITDA
-39 483
-39 203
0
-78 686
Operational EBIT
-116 399
-44 404
1 896
-158 906
Fair value adjustment of biomass
15 630
0
0
15 630
Net financial
-137 443
109 119
-0,00
-28 324
Profit/loss before tax
-238 212
64 715
1 896
-171 601
Harvested volum (tonnes, HOG)
4 403
4 403
Operational EBITDA/kg (NOK)
-9,0
-17,9
Operational EBIT/kg (NOK)
-26,4
-36,1
Total PPE
3 644 993
33 459
38 636
3 717 088
Note 3 Biological assets and inventory
Biological assets are, in accordance with IAS 41, measured at fair value. For salmon in the grow-out facility, a present value model is applied to estimate the fair value. For roe, fry and smolt, historical cost is deemed to provide the best estimate of fair value, and hence applied.
The fair value of fish in the grow-out facility is calculated by multiplying the estimated biomass at the time of harvest with the estimated sales price at the same time and deducted for estimated costs to sell. For fish not ready for harvest, remaining production costs to grow the fish to harvest weight are deducted. The cash flow is further discounted by a discount rate considering both risk adjustment and time value.
The Company considers that fish greater than 4.6 kg is ready for harvest (about 3.8 kg gutted weight), and such fish is thus classified as harvestable fish. Fish that have not achieved this weight are classified as non-harvestable.
In the event of incident-based mortality, all costs allocated to fish affected by incident-based mortality will be deducted from the book value of the inventory.
Book value of inventory
(in NOK thousand)
Q2 2026
Q1 2026
Q2 2025
Equipment
7 492
6 720
6 742
Raw materials
4 325
5 011
2 911
Biological assets
206 852
172 512
195 512
Finished goods
0
0
0
Total
218 669
184 243
205 165
Biological assets
(tonnes)
Q2 2026
Q1 2026
Q2 2025
Biological assets end of period
2 897
2 334
3 043
Biological assets
(in NOK thousand)
Q2 2026
Q1 2026
Q2 2025
FY 2025
Biological assets beginning of period
172 512
232 335
202 350
171 004
Increase due to production
112 945
97 223
111 014
411 389
Reduction due to harvest/sale
-73 106
-130 180
-108 830
-365 687
Fair value adjustment beginning of period
-10 155
-37 021
-2 135
-21 391
Fair value adjustment end of period
4 657
10 155
-6 887
37 021
Biological assets end of period
206 852
172 512
195 512
232 335
The estimated biomass volume is based on the actual number of individuals in the grow-out departments on the balance sheet date, adjusted for projected mortality up to harvest time and multiplied with the estimated harvest weight per individual at harvest time.
The estimated sales price for the fish in the grow-out facility is based on forward prices from Sisalmoni with relevant adjustments. The net sales value is adjusted for expected quality differences and harvesting, logistics and sales expenses.
Note 4 Property, plant, equipment, right of use- and intangible asset
Straight-line depreciation is applied over the useful life of property, plant, and equipment based on the asset’s historical cost and estimated residual value at disposal. Depreciation is charged to expense when the property, plant or equipment is ready for intended use.
(in NOK thousand)
Intangible assets
Assets under construction
Buildings and property
Fixtures and fittings
Right-of-use assets
Total
Cost 1 January 2025
81 136
481 778
1 598 740
342 102
33 185
2 536 940
Additions
2 710
553 604
277
9 441
34 805
600 836
Cost 30 June 2025
83 845
1 035 382
1 599 016
351 543
67 990
3 137 776
Acc. depreciation 1 January 2025
-34
0
-68 077
-48 480
-15 328
-131 919
Depreciation for the period
-1 479
0
-20 369
-16 255
-4 408
-42 511
Net book value 30 June 2025
82 331
1 035 382
1 510 570
286 808
48 254
2 963 345
(in NOK thousand)
Intangible assets
Assets under construction
Buildings and property
Fixtures and fittings
Right-of-use assets
Total
Cost 1 January 2026
86 346
1 781 080
1 625 586
361 493
70 471
3 924 976
Additions
315
630 223
242
6 269
1 497
638 545
Cost 30 June 2026
86 660
2 411 303
1 625 828
367 762
71 968
4 563 521
Acc. depreciation 1 January 2026
-1 838
0
-108 880
-72 212
-24 957
-207 889
Depreciation for the period
-847
0
-20 985
-13 875
-5 142
-40 848
Net book value 30 June 2026
83 975
2 411 303
1 495 963
281 675
41 869
4 314 786
Note 5 Finance income and finance cost
Finance income
(in NOK thousand)
Q2 2026
Q2 2025
YTD 2026
YTD 2025
2025
Interest income
455
2 950
465
6 933
5 916
Foreign exchange gains
1 483
1 481
2 389
1 812
3 811
Other finance income
608
19
1 549
19
19
Financial income
2 546
4 449
4 402
8 764
9 746
Share of net income from associated companies
100
-1 196
-562
-4 348
-5 477
Total financial income
2 645
3 253
3 840
4 415
4 269
Finance expenses
(in NOK thousand)
Q2 2026
Q2 2025
YTD 2026
YTD 2025
2025
Interest on debts and borrowings
72 384
21 750
111 188
39 659
110 508
Capitalised borrowing costs - general borrowings
-10 229
0
-20 258
0
-36 742
Capitalised borrowing costs - specific borrowings
-55 115
-8 599
-76 338
-14 039
-44 413
Realized loss/gain on interest derivative
-1 599
-1 442
-3 233
-2 950
-6 019
Change in value of financial derivatives (loss)
1 915
5 543
-5 631
5 116
3 005
Foreign exchange losses
1 918
1 659
4 550
2 091
5 340
Other finance expenses
69
220
287
449
914
Total financial expenses
9 343
19 131
10 564
30 325
32 593
Net financial income/- expenses
-6 698
-15 878
-6 724
-25 910
-28 324
Application of IAS 23 has been taken into consideration where the Company has general borrowings which has partly been financing qualifying assets but not been directly allocated to the construction of a qualifying asset.
The Company did not have any fair value adjustments of financial liabilities in H1 2026, nor in 2025.
Note 6 Tax
(in NOK thousand)
YTD 2026
YTD 2025
Profit/loss before tax
-81 627
-126 447
Calculated tax (22%)
-17 958
-27 818
Tax payable
0
0
Change in deferred tax (asset)
-17 958
-27 818
Change in deferred tax not recognised in the balance sheet
17 958
27 818
Tax expense
0
0
Income tax expense is recognised based on management’s estimate of the weighted average effective annual income tax rate expected for the full financial year. The estimated average annual tax rate used for the period ended 30 June 2026 is 22%, compared to 22% for the period ended 30 June 2025.
Deferred tax benefit has not been recognised in the balance sheet as the Companies within the group are in their start-up phase and does not have any historical results to refer to when assessing whether future taxable profits will be sufficient to utilize the tax benefit.
Note 7 Earnings per share
(in NOK thousand)
YTD 2026
YTD 2025
Gain/loss attributable to the equity owners of the Group
-81 627
-126 447
Gain/loss for calculation of diluted earnings per share
-81 627
-126 447
Weighted average number of shares outstanding1)
493 069 973
462 603 306
Dilutive options
0
0
Average number om shares and options used in calculation for diluted EPS
493 069 973
462 603 306
Basic earnings per share (NOK)
-0,17
-0,27
Diluted earnings per share (NOK)
-0,17
-0,27
Basic earnings per share are based on the weighted average number of common shares outstanding during the period.
H1 2026: The Company had 462,603,306 shares until April 30 and subsequently increased the number to 554,003,306 following a private placement.
H1 2025: The Company had 462,603,306 shares for the whole period.
Note 8 Share capital & capital history
(in NOK thousand)
Date
Capital Increase
Share Capital After Change
Par Value
Subscription price per share
New shares
Total no. of outstanding shares
Opening balance 1 July 2020
5 375 159
0,05
107 503 182
Share options exercised
10 July 2020
30 000
5 405 159
0,05
3,33
600 000
108 103 182
Private placement
23 July 2020
581 395
5 986 554
0,05
4,30
11 627 906
119 731 088
Private placement
11 September 2020
5 000 000
10 986 554
0,05
5,00
100 000 000
219 731 088
Private placement
23 March 2021
4 166 667
15 153 221
0,05
6,00
83 333 333
303 064 421
Acquisition Kraft Laks
16 August 2021
109 535
15 262 756
0,05
7,58
2 190 694
305 255 115
Private placement
12 October 2021
277 068
15 539 824
0,05
7,71
5 541 374
310 796 489
Share options exercised
26 March 2022
81 250
15 621 074
0,05
4,80
1 625 000
312 421 489
Private placement
5 April 2022
1 666 667
17 287 741
0,05
9,00
33 333 333
345 754 822
Private placement
18 April 2023
3 409 091
20 696 832
0,05
7,70
68 181 818
413 936 640
Private placement
18 June 2024
2 433 333
23 130 165
0,05
7,50
48 666 666
462 603 306
Private placement
30 April 2026
4 570 000
27 700 165
0,05
4,50
91 400 000
554 003 306
The Company entered into an investment agreement with Dongwon Industries and completed a NOK 50 million in towards Dongwon Industries in July 2020.
The Company raised NOK 500 million in a private placement in connection with its initial public offering related to the admission on Merkur Market (now Oslo Børs) in September 2020. Further, the Company also raised another NOK 500 million in a private placement in March 2021.
In August 2021 the Company acquired 100% of the shares in Kraft Laks AS. As part of the settlement the Company issued 2,190,694 new shares of NOK 7.6 per share and thereby increased its equity by NOK 16.6 million. In October 2021 the Company carried out a private placement of USD 5m (NOK ~43m) towards Cargill.
Further, in April 2022 the Company carried out a private placement raising gross proceeds of NOK 300 million at a subscription price of NOK 9.0 per share.
In April 2023 the Company carried out a private placement raising gross proceed of NOK 525 million at a subscription price of NOK 7.7 per share.
In June 2024 the Company carried out a private placement raising gross proceed of NOK 365 million at a subscription price of NOK 7.5 per share.
Finally, in April 2026, the Group carried out a private placement that raised gross proceed of NOK 411 million at a subscription price of NOK 4.5 per share.
Note 9 Interest bearing debt
Long-term interest bearing dept
(in NOK thousand)
30.06.2026
30.06.2025
Debt to credit institutions
2 073 031
818 500
Leasing liabilities
27 041
32 595
Total long-term interest-bearing debt
2 100 072
851 095
Short-term interes bearing dept
(in NOK thousand)
30.06.2026
30.06.2025
Debt to credit institutions
209 235
207 253
Leasing liabilitites
10 910
10 481
Total short-term interest-bearing debt
220 145
217 734
Total interest-bearing debt
2 320 216
1 068 829
Cash & cash equivalents
280 561
128 760
Net interest-bearing debt
2 039 655
940 069
In April 2026 Salmon Evolution refinanced and expanded its existing senior secured debt financing package related to Indre Harøy Phase 1 and 2, from 2,225 NOKm to 2,475 NOKm. The Company also increase the existing 200 NOKm overdraft facility related to biomass and receivables financing in phase 1 up to 400 NOKm for phases 1 and 2. Currently 200 NOKm of the 400 NOKm permitted is available to the Company.
As per 30 June 2026, 2,031 NOKm was drawn of the secured green debt financing package. In addition, the Company has drawn 198 NOKm, of the 200 NOKm available under the Overdraft Facility.
The Company has also entered into loan agreements for a total of NOK 60 million relating to Salmon Evolution Dale AS of which around NOK 54 million was drawn as per 30 June 2026. This loan is for financing of working capital, investments in Salmon Evolution Dale as well as refinancing of the seller’s credit from the acquisition of Salmon Evolution Dale AS. The above table does not include other long-term liabilities of NOK 3.6 million related to water rights in Salmon Evolution Dale AS.
The loans are floating interest rate loans denominated in NOK with an interest charge based on NIBOR 3M plus an agreed margin.
Financial covenants
The most important financial covenants for the long-term financing of the Company are, respectively, a solvency requirement that the borrower’s (Salmon Evolution Norway AS) book equity ratio (including intra-group loans) shall be minimum 45%. Further, there is a profitability requirement linked to the borrower’s EBITDA which shall be greater than NOK 358 million on a last 12-month basis from Q2 2028.
Finally, there is a minimum cash requirement that stipulates that the obligors (Salmon Evolution Norway AS, Salmon Evolution Sales AS and Salmon Evolution ASA) cash balance shall be greater than NOK 100 million at any time. Any undrawn and available amounts under the revolving facility and the overdraft is included in the calculation of the cash balance.
Security
The Company’s bank debt facilities are fully guaranteed by Salmon Evolution ASA. The respective lenders also have a pledge over 100% of the shares in the borrower, Salmon Evolution Norway AS and Salmon Evolution Dale AS. Furthermore, the respective lenders have a pledge over all material operating assets of the Company, hereunder inter alia, land, plant and machinery, operating licenses, inventory and receivables.
Cash movements in financial activities
(NOK thousand)
Short term
Long term
Balance at January 1, 2025
163 805
582 411
Repayment of loans and borrowings
0
-600
Proceeds from new bank loan
48 765
250 000
Change in leases liabilities
5 164
22 927
Balance at June 30, 2025
217 734
854 738
Balance at January 1, 2026
345 558
1 578 959
Repayment of loans and borrowings
-160 000
-600
Proceeds from new bank loan
34 664
524 760
Change in leases liabilities
-77
-3 047
Balance at June 30, 2026
220 145
2 100 072
Note 10 Transactions with related parties
During the ordinary course of business, the Company may engage in certain arm’s length transactions with related parties.
There were no material transactions with related parties in H1 2026, nor in 2025.
Note 11 Subsequent events
No material subsequent events.
ABOUT SALMON EVOLUTION
Salmon Evolution is the global leader within land-based salmon farming. Pioneering the hybrid flow-through system (HFS), Salmon Evolution is Extending the Ocean Potential by creating optimal growth conditions in a controlled environment on land. This approach, capturing the benefits of both land-based and sea-based farming, puts biology first and limits operational and biological risk.
Salmon Evolution is strategically located the heart of the global aquaculture industry on the west coast of Norway, where the Company has its first facility and global centre of excellence fully operational at industrial scale. Enabled by proof of concept in at Indre Harøy, Salmon Evolution targets significant expansion.
Salmon Evolution is listed on Oslo Børs under the ticker SALME. To learn more, please visit www.salmonevolution.no.